Nehal Chopra Ratan Capital Management
Nehal Chopra is the founder of Ratan Capital Management, a concentrated investment firm whose public portfolio is followed for high-conviction equity ideas. The firm’s filings often show a focused set of positions rather than a broad index-like book. Investors track Ratan as an example of a smaller, research-driven manager with differentiated stock selection.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Post Holdings
POST
|
+$77.3M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$45M |
| 3 |
Kraft Heinz
KHC
|
+$5.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$168M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$104M |
| 3 |
AGN
Allergan plc
AGN
|
+$62.9M |
| 4 |
Viatris
VTRS
|
+$61.4M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$59.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 40.65% |
| 2 | Healthcare | 32.1% |
| 3 | Communication Services | 22.51% |
| 4 | Financials | 2.58% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Post Holdings
POST
$3.65B
| $76.2M | 16.64% |
+1,968,987
| New | +$77.3M |
|
2
Coty
COTY
$2.41B
| $62.8M | 13.72% |
2,320,033
-157,917
| -6% | -$4.49M |
|
3
Charter Communications
CHTR
$17.9B
| $60.1M | 13.13% |
341,600
-189,846
| -36% | -$34.6M |
|
|
4
Bausch Health
BHC
$2.41B
| $56.6M | 12.38% |
317,561
-720,472
| -69% | -$168M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $51.2M | 11.2% |
188,544
-204,649
| -52% | -$62.9M |
|
6
Liberty Global Class A
LBTYA
$3.63B
| $42.9M | 9.38% |
1,145,505
-445,253
| -28% | -$19.3M |
|
|
PF
7
DELISTED
Pinnacle Foods, Inc.
PF
| $41.9M | 9.15% |
999,330
-1,245,241
| -55% | -$56.3M |
|
|
ENDP
8
DELISTED
Endo International plc
ENDP
| $39M | 8.52% |
+562,699
| New | +$45M |
|
9
Hilltop Holdings
HTH
$2.22B
| $11.8M | 2.58% |
596,884
| – | – |
|
|
HZNP
10
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $9.91M | 2.17% |
+500,000
| New | +$15.8M |
|
|
11
Kraft Heinz
KHC
$30.3B
| $5.24M | 1.15% |
+74,240
| New | +$5.6M |
|
12
PUT
Fossil Group
FOSL
$332M
| – | – |
-300,000
| Closed | -$20.8M |
|
13
SS&C Technologies
SSNC
$19.5B
| – | – |
-400,000
| Closed | -$12.5M |
|
|
14
Teva Pharmaceuticals
TEVA
$43.5B
| – | – |
-1,000,000
| Closed | -$59.1M |
|
|
15
Viatris
VTRS
$18.7B
| – | – |
-905,000
| Closed | -$61.4M |
|
|
HZNP
16
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-1,321,300
| Closed | -$41.7M |
|
|
CPN
17
DELISTED
Calpine Corporation
CPN
| – | – |
-2,108,766
| Closed | -$37.9M |
|
|
TWC
18
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| – | – |
-584,797
| Closed | -$104M |
|
Similar funds
Nehal Chopra's Q3 2015 Portfolio in Review
As of Q3 2015, Nehal Chopra held 18 positions worth $458M, down 56% from $1.05B the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Nehal Chopra withdrew a net $540M in Q3 2015, closing 7 positions and reducing 6 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $104M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 41% of assets, up from 17% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Nehal Chopra opened a new position in Post Holdings worth $76.2M.
- Nehal Chopra's largest Q3 2015 buy was Post Holdings: 1,968,987 shares worth $76.2M.
- Nehal Chopra's biggest Q3 2015 reduction was Bausch Health, cutting an estimated $168M.
- Nehal Chopra fully exited TIME WARNER CABLE INC NEW COM STK in Q3 2015, selling an estimated $104M.
- Nehal Chopra's ten largest holdings make up 99% of its $458M portfolio in Q3 2015.
- Nehal Chopra opened 4 new positions and closed 7 in Q3 2015.
- Nehal Chopra's portfolio value fell 56% quarter-over-quarter to $458M.
Based on Ratan Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.